Significance of BRAF mutations in papillary thyroid carcinoma: prognostic and therapeutic implications
- 1 April 2006
- journal article
- Published by Springer Nature in Nature Clinical Practice Endocrinology & Metabolism
- Vol. 2 (4) , 180-181
- https://doi.org/10.1038/ncpendmet0161
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Inhibitors of Raf Kinase Activity Block Growth of Thyroid Cancer Cells with RET/PTC or BRAF Mutations In vitro and In vivoClinical Cancer Research, 2006
- PAX8-PPARγ Rearrangement Is Frequently Detected in the Follicular Variant of Papillary Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2006
- BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2005
- High Prevalence and Possible de Novo Formation of BRAF Mutation in Metastasized Papillary Thyroid Cancer in Lymph NodesJournal of Clinical Endocrinology & Metabolism, 2005
- Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysisOncogene, 2005
- BRAF mutation in thyroid cancerEndocrine-Related Cancer, 2005
- Targeted Expression of BRAFV600E in Thyroid Cells of Transgenic Mice Results in Papillary Thyroid Cancers that Undergo DedifferentiationCancer Research, 2005
- Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancerJournal of Clinical Investigation, 2005
- BRAF Mutations in Thyroid Tumors Are Restricted to Papillary Carcinomas and Anaplastic or Poorly Differentiated Carcinomas Arising from Papillary CarcinomasJournal of Clinical Endocrinology & Metabolism, 2003